Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorDana-Farber Cancer Institute
About this trial
The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.
Eligibility criteria
Qualifiers
Age ≥ 21 years
Current or previous diagnosis of advanced cancer
Current or previous experience with cancer pain
Disqualifiers
Inability to understand, speak, or read English
Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.
Trial design
Treatments tested in this trial
- I-STAMP
Treatment groups
73 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov